Market Snapshot

BSE Sensex: 84774.96 -0.51%
BSE 500: 37054.74 -0.48%
BSE 200: 11696.23 -0.46%
BSE 100: 27114.91 -0.46%
BSE MidCap: 46271.1 -0.60%
BSE SmallCap: 50851.32 -0.48%
BSE BANKEX: 66182.2 -0.79%
BSE IT: 36770.66 -0.94%
Nifty 50: 25904.85 -0.47%
Nifty 500: 23608.55 -0.49%
Nifty 200: 14391.7 -0.49%
Nifty 100: 26434.8 -0.45%
Nifty Midcap 100: 59834.9 -0.63%
Nifty Small 100: 17303.6 -0.70%
Nifty IT: 38020.7 -0.95%
Nifty PSU Bank: 8234.85 -0.61%

News:

Ion Exchange climbs after bagg...
GMR Airports passenger traffic...
Sterling Tools drop after CFO ...
HDFC Bank gets RBI nod to hold...
Nucleus Software rises as Viet...

Solara Active Pharma Sciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

16 Dec 2025 | 10:37 AM

587.65

-4.15 (-0.70%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-18.72%

Return (1Y)

Underperformed BSE Healthcare by 18.33%
More Volatile

3.17%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.2%
Not so consistent

5/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

766

441

News & Announcements

Solara Active Pharma's Mangalore facility successfully concludes US FDA audit
27 days ago

Solara Active Pharma's Mangalore facility successfully concludes US FDA audit

19 - Nov - 2025 12:00 | 27 days ago

The aforementioned inspection was conducted between August 25th to 29th, 2025.
The agency has issued an EIR (Establishment Inspection Report) on 18th Nov 2025 and determined that the inspection classification of the facility is ?voluntary action indicated (VAI)? and concluded this inspection as closed.
Sandeep Rao, MD & CEO said ?We have successfully completed the FDA inspection at our Mangalore facility between 25th to 29th Aug 2025.
At the end of the inspection, two Form FDA 483 inspectional observations were issued by the investigator. The observations were procedural in nature.
We had submitted our formal response to FDA well within the timeline set by the agency and the agency has issued an EIR and concluded that the inspection is closed.?
Solara Active Pharma Sciences is a pure play global API manufacturer supported by R&D and manufacturing facilities.
The scrip declined 2.05% to currently trade at Rs 561.05 on the BSE.

Powered by Capital Market - Live News
Solara Active Pharma Sciences' Mangalore unit completes USFDA inspection
27 days ago

Solara Active Pharma Sciences' Mangalore unit completes USFDA inspection

19 - Nov - 2025 12:00 | 27 days ago

Solara Active Pharma Sciences announced that its multi-product manufacturing facility at Mangalore, Karnataka has successfully completed the inspection carried out by the US Food and Drug Administration (US FDA) between 25 to 29 August 2025. The Agency has issued an EIR (Establishment Inspection Report) on 18th Nov 2025 and determined that the inspection classification of the facility is ?Voluntary Action Indicated (VAI)? and concluded this inspection as closed.
Powered by Capital Market - Live News
Solara Active Pharma Sciences reports consolidated net loss of Rs 10.10 crore in the September 2025 quarter
41 days ago

Solara Active Pharma Sciences reports consolidated net loss of Rs 10.10 crore in the September 2025 quarter

05 - Nov - 2025 12:00 | 41 days ago

Net loss of Solara Active Pharma Sciences reported to Rs 10.10 crore in the quarter ended September 2025 as against net profit of Rs 8.01 crore during the previous quarter ended September 2024. Sales declined 9.63% to Rs 313.54 crore in the quarter ended September 2025 as against Rs 346.95 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 313.54 346.95 -10

OPM % 11.08 17.67 -

PBDT 14.39 33.35 -57

PBT -10.10 8.01 PL

NP -10.10 8.01 PL

Powered by Capital Market - Live News
Solara Active Pharma Sciences to hold board meeting
47 days ago

Solara Active Pharma Sciences to hold board meeting

30 - Oct - 2025 12:00 | 47 days ago

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 5 November 2025.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Solara Active Pharma Sciences Ltd has decreased by -4.73% since past 3 Months
FII shareholding in Solara Active Pharma Sciences Ltd has decreased by -4.71% since past 1 Year
MF shareholding in Solara Active Pharma Sciences Ltd has decreased by -8.16% since past 1 Year
Promoter shareholding in Solara Active Pharma Sciences Ltd has increased by 12.74% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	313.54	346.95	-10
OPM %	11.08	17.67	-
PBDT	14.39	33.35	-57
PBT	-10.10	8.01	PL
NP	-10.10	8.01	PL

General Notifications

My Notifications

Research Notifications

Solara Active Pharma Sciences Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

587.65 -4.15 (-0.70%)

News & Announcements

Price vs Volume

Stock Trivia

Solara Active Pharma Sciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

587.65

-4.15 (-0.70%)